STOCK TITAN

Modular Medical to Present at the Webull Emerging & Innovative Companies Webinar on October 14th

Modular Medical (NASDAQ:MODD) will present at the Webull Emerging & Innovative Companies Webinar on October 14, 2026.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Modular Medical (NASDAQ:MODD) will present at the Webull Emerging & Innovative Companies Webinar on October 14, 2026. Chief Executive Officer Jeb Besser will give the presentation at 1:00 p.m. ET. A webcast will be available through the company's investor relations website.

Loading...
Loading translation...
Argus 15 min delay 8 alerts
+8.06% vs previous close $2.95 last price 6.7x rel. volume Open Argus
Details

Market move: MODD +8.06% vs previous close. CEO webinar presentation

$2.47 – $3.05 Day Range
$24.04M Market Cap

On Oct 7, the day this news came out, the latest delayed price for MODD is 8.06% above the previous close. Our momentum scanner has recorded 8 alerts for this stock so far that day. The latest delayed price is $2.95. Relative volume is exceptionally heavy at 6.7x the average.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Terms

continuous subcutaneous insulin infusion
1 terms
continuous subcutaneous insulin infusion medical
"continuous subcutaneous insulin infusion with both basal and bolus insulin delivery"
A therapy that uses a small wearable pump to deliver insulin under the skin through a thin tube, providing a steady baseline dose plus extra doses around meals to control blood sugar. Think of it like an automated drip and on-demand button combined, replacing multiple daily injections. It matters to investors because pump sales, consumable supplies, software updates, regulatory approvals and reimbursement policies drive revenue, adoption rates and competitive dynamics in the diabetes care market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SAN DIEGO, CA / ACCESS Newswire / October 7, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial launch of its next-generation Pivot™ tubeless patch pump, today announced that Chief Executive Officer, Jeb Besser, will present at the Webull Emerging & Innovative Companies Webinar, on Wednesday, October 14, 2026.

Webull Emerging & Innovative Companies Webinar

Presentation Date and Time: Wednesday, October 14, 2026 at 1:00 p.m. ET

Webcast: https://ir.modular-medical.com/events.php

To schedule a one-on-one meeting with Mr. Besser, please email KCSA Strategic Communications at ModularMedical@KCSA.com.

About the Pivot Tubeless Patch Pump

The Pivot™ tubeless patch pump is a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal and bolus insulin delivery over a three-day wear period. The system is intended to offer a practical and accessible pathway from multiple daily injections to insulin pump therapy for a broader population of people living with diabetes. For more information, visit www.pivotpump.com.

About Modular Medical

Modular Medical, Inc. (NASDAQ:MODD) is a commercial-stage medical device company focused on the development of innovative insulin delivery technologies designed to simplify diabetes management and increase access to insulin pump therapy. The Company's Pivot™ tubeless patch pump has been developed to provide a user-friendly, flexible, and accessible approach to insulin delivery for people requiring intensive insulin therapy.

Company Contact:

Jeb Besser, Chief Executive Officer
Modular Medical, Inc.
IR@modular-medical.com

Investor Contact:

Valter Pinto, Managing Director
KCSA Strategic Communications
ModularMedical@KCSA.com

SOURCE: Modular Medical, Inc.



View the original press release on ACCESS Newswire

Keep reading